These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 14764652

  • 21. Dual effects of daidzein on chicken hepatic vitellogenin II expression and estrogen receptor-mediated transactivation in vitro.
    Ni YD, Hong WJ, Zhou YC, Grossmann R, Zhao RQ.
    Steroids; 2010 Mar; 75(3):245-51. PubMed ID: 20043933
    [Abstract] [Full Text] [Related]

  • 22. Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.
    Cvoro A, Paruthiyil S, Jones JO, Tzagarakis-Foster C, Clegg NJ, Tatomer D, Medina RT, Tagliaferri M, Schaufele F, Scanlan TS, Diamond MI, Cohen I, Leitman DC.
    Endocrinology; 2007 Feb; 148(2):538-47. PubMed ID: 17095596
    [Abstract] [Full Text] [Related]

  • 23. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
    Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS.
    Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
    [Abstract] [Full Text] [Related]

  • 24. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V, Bellastella G, De Rosa C, Abbondanza C, Visconti D, Maione L, Chieffi P, Della Ragione F, Prezioso D, De Bellis A, Bellastella A, Sinisi AA.
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [Abstract] [Full Text] [Related]

  • 25. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest.
    Zuo Z, Urban G, Scammell JG, Dean NM, McLean TK, Aragon I, Honkanen RE.
    Biochemistry; 1999 Jul 13; 38(28):8849-57. PubMed ID: 10413457
    [Abstract] [Full Text] [Related]

  • 26. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.
    Monroe DG, Getz BJ, Johnsen SA, Riggs BL, Khosla S, Spelsberg TC.
    J Cell Biochem; 2003 Oct 01; 90(2):315-26. PubMed ID: 14505348
    [Abstract] [Full Text] [Related]

  • 27. A distal estrogen responsive element upstream the cap site of human transthyretin gene is an enhancer-like element upon ERα and/or ERβ transactivation.
    Martinho A, Santos CR, Gonçalves I.
    Gene; 2013 Sep 25; 527(2):469-76. PubMed ID: 23860318
    [Abstract] [Full Text] [Related]

  • 28. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
    Hall JM, McDonnell DP.
    Endocrinology; 1999 Dec 25; 140(12):5566-78. PubMed ID: 10579320
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.
    Evers NM, van de Klundert TM, van Aesch YM, Wang S, de Roos WK, Romano A, de Haan LH, Murk AJ, Ederveen AG, Rietjens IM, Groten JP.
    Toxicol In Vitro; 2013 Sep 25; 27(6):1753-61. PubMed ID: 23680332
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cross-inhibition of both estrogen receptor alpha and beta pathways by each dominant negative mutant.
    Ogawa S, Inoue S, Orimo A, Hosoi T, Ouchi Y, Muramatsu M.
    FEBS Lett; 1998 Feb 20; 423(2):129-32. PubMed ID: 9512344
    [Abstract] [Full Text] [Related]

  • 33. Sodium arsenite inhibited genomic estrogen signaling but induced pERα (Ser118) via MAPK pathway in breast cancer cells.
    Nakareangrit W, Thiantanawat A, Visitnonthachai D, Watcharasit P, Satayavivad J.
    Environ Toxicol; 2016 Sep 20; 31(9):1133-46. PubMed ID: 25728338
    [Abstract] [Full Text] [Related]

  • 34. Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene.
    Daverey A, Saxena R, Tewari S, Goel SK, Dwivedi A.
    J Steroid Biochem Mol Biol; 2009 Aug 20; 116(1-2):93-101. PubMed ID: 19460436
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Estrogenically regulated LRP16 interacts with estrogen receptor alpha and enhances the receptor's transcriptional activity.
    Han WD, Zhao YL, Meng YG, Zang L, Wu ZQ, Li Q, Si YL, Huang K, Ba JM, Morinaga H, Nomura M, Mu YM.
    Endocr Relat Cancer; 2007 Sep 20; 14(3):741-53. PubMed ID: 17914104
    [Abstract] [Full Text] [Related]

  • 37. Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription.
    Duplessis TT, Williams CC, Hill SM, Rowan BG.
    Endocrinology; 2011 Jun 20; 152(6):2517-26. PubMed ID: 21505052
    [Abstract] [Full Text] [Related]

  • 38. Constitutive over expression of serine/threonine protein phosphatase 5 (PP5) augments estrogen-dependent tumor growth in mice.
    Golden T, Aragon IV, Zhou G, Cooper SR, Dean NM, Honkanen RE.
    Cancer Lett; 2004 Nov 08; 215(1):95-100. PubMed ID: 15374638
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Fatty acids derived from royal jelly are modulators of estrogen receptor functions.
    Moutsatsou P, Papoutsi Z, Kassi E, Heldring N, Zhao C, Tsiapara A, Melliou E, Chrousos GP, Chinou I, Karshikoff A, Nilsson L, Dahlman-Wright K.
    PLoS One; 2010 Dec 22; 5(12):e15594. PubMed ID: 21203528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.